Evidence map›Paper›PMID 34569727›Full record

ArticleCancer medicine2021

Construction of circRNA-based ceRNA network and its prognosis-associated subnet of clear cell renal cell carcinoma.

Yuwei Zhang, Yuchen Zhang, Yangkun Feng, Nan Zhang, Saisai Chen, Chaoqun Gu, Lei Hu, Jiayi Sheng, Bin Xu, Ninghan Feng

Abstract read
In one paragraph

Article in Cancer medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yuwei ZhangDepartment of Urology, Affiliated Wuxi No. 2 Hospital of Nanjing Medical University, Wuxi, China.ORCID 0000-0003-1337-1081
Yuchen ZhangDepartment of Oncology, First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Yangkun FengMedical College of Nantong University, Nantong, China.
Nan ZhangDepartment of Urology, Affiliated Wuxi No. 2 Hospital of Nanjing Medical University, Wuxi, China.
Saisai ChenDepartment of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing, China.
Chaoqun GuMedical College of Nantong University, Nantong, China.
Lei HuDepartment of Urology, Affiliated Wuxi No. 2 Hospital of Nanjing Medical University, Wuxi, China.
Jiayi ShengDepartment of Urology, Affiliated Wuxi No. 2 Hospital of Nanjing Medical University, Wuxi, China.
Bin XuDepartment of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing, China.
Ninghan FengDepartment of Urology, Affiliated Wuxi No. 2 Hospital of Nanjing Medical University, Wuxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circular RNAs (circRNAs) are novel biomarkers of various cancers. CircRNAs can sponge miRNAs and regulate target mRNAs, which was called competing endogenous RNAs (ceRNA). This study was designed to identify circRNAs related to patients with clear cell renal cell carcinoma (ccRCC) and the first to select three independent Gene Expression Omnibus microarrays covering circRNAs, miRNAs, and mRNAs for multiple analyses. The data of clinical cases applied in our study were obtained from The Cancer Genome Atlas. We successfully conducted a circRNA/miRNA/mRNA ceRNA network related to ccRCC patients via R software and Cytoscape including 8 circRNAs, 6 miRNAs, and 49 mRNAs. The prognosis-associated subnet covered 8 circRNAs, 6 miRNAs, and 22 mRNAs. Quantitative real-time PCR was applied to measure our prediction in three renal cell lines and 23 pairs of tissues. Small interfering RNA targeting the back-splice region of hsa_circ_0001167 was further implied to confirm the regulation. Ultimately, hsa_circ_0001167/hsa-miR-595/CCDC8 regulatory axis was identified in this study, which may serve as prognostic indicators. Lower levels of hsa_circ_0001167 and CCDC8 were potentially correlated with worse patient survival.

Indexed as

Carcinoma, Renal CellCell Line, TumorGene Regulatory NetworksHumansKidney NeoplasmsPrognosisRNA, CircularRNA, MessengerTransfectionRNA, CircularRNA, MessengerCCDC8ceRNA networkcircRNAclear cell renal cell carcinoma (ccRCC)has_circ_0001167prognosis

Identifiers

PMID34569727
PMCPMC8607260

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.